Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001615774-15-002385

Options or other derivatives

  • Director acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
FOLLMAN ROBERT J Director 2015-08-20 Grant or award · Option to Purchase +250,000 250,000 D
Loading xslF345X03/s101748_form4.xml…